Cargando…

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer

BACKGROUND: Expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate with favourable clinicopathological parameters and prognosis in several cancer diseases. The aim of this study was to examine the expression and prognostic ability of RBM3 in patients with testicular non-sem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olofsson, Sven-Erik, Nodin, Björn, Gaber, Alexander, Eberhard, Jakob, Uhlén, Mathias, Jirström, Karin, Jerkeman, Mats
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374873/ https://www.ncbi.nlm.nih.gov/pubmed/25811459 http://dx.doi.org/10.1371/journal.pone.0121300

Ejemplares similares

Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
por: Karnevi, Emelie, et al.
Publicado: (2017)

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
por: Nodin, Björn, et al.
Publicado: (2012)

Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma
por: Fristedt, Richard, et al.
Publicado: (2014)

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study
por: Jonsson, Liv, et al.
Publicado: (2011)

High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death
por: Jonsson, Liv, et al.
Publicado: (2014)

Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020)

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
por: Ehlén, Åsa, et al.
Publicado: (2010)

SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma
por: Hedner, Charlotta, et al.
Publicado: (2014)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome
por: Bengtsson, Erik, et al.
Publicado: (2014)

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
por: Jonsson, Liv, et al.
Publicado: (2011)

Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non‐small cell lung cancer
por: Salomonsson, Annette, et al.
Publicado: (2020)

Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
por: Berntsson, Jonna, et al.
Publicado: (2014)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
por: Fristedt, Richard, et al.
Publicado: (2014)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
por: Larsson, Anna H, et al.
Publicado: (2013)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor
por: Ueda, Takashi, et al.
Publicado: (2022)

Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor
por: Xavier, Rosana, et al.
Publicado: (2020)

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
por: Wangefjord, Sakarias, et al.
Publicado: (2011)

PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
por: Olsson Hau, Sofie, et al.
Publicado: (2021)

Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
por: Anand, Madhur
Publicado: (2021)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors
por: Green, Daniel B., et al.
Publicado: (2021)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Testicular seminomatous mixed germ cell tumor with choriocarcinoma and teratoma with secondary somatic malignancy: a case report
por: Aneja, Amandeep, et al.
Publicado: (2014)

Testicular non-seminomatous mixed germ cell tumor with rhabdomyosarcoma and retroperitoneal metastatic mass: A case report
por: Sammour, Mohammed, et al.
Publicado: (2020)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014)

Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
por: Eberhard, J, et al.
Publicado: (2012)

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
por: Wahlin, Sara, et al.
Publicado: (2022)

Testicular non-seminomatous germ cell tumors (NSGCT) and brain metastases: About a rare location of the posterior fossa
por: Borni, Mehdi, et al.
Publicado: (2018)

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
por: Fankhauser, Christian Daniel, et al.
Publicado: (2019)

Outcome of testicular non-seminomatous germ cell tumours: report from a tertiary cancer centre in eastern India
por: Biswas, Bivas, et al.
Publicado: (2021)

Clinical characteristics of testicular non-seminomatous germ cell tumor from West China: a 10-year experience
por: Chen, Zeyu, et al.
Publicado: (2022)

The management of low-stage non-seminomatous germ cell tumors
por: Lim, Louise, et al.
Publicado: (2012)

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
por: Larsson, Anna H., et al.
Publicado: (2016)

Spontaneous regression as a ‘burned-out’ non-seminomatous testicular germ cell tumor: a case report and literature review
por: Dorantes-Heredia, Rita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qo6sq4qrn541evvcfgij3t1rar